课题基金 / 基金详情

Directed evolution of RNA ligases for high-throughput sequencing

Directed evolution of RNA ligases for high-throughput sequencing
用于高通量测序的 RNA 连接酶的定向进化
批准号:
8060619
负责人:
Andrew D Ellington
金额:
$22.37万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2013-03-31

项目摘要

项目成果

Andrew D Ellington的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): While NextGen sequencing of small RNAs will provide important insights into a variety of biological processes the sequencing process is inherently biased, either by library construction or by RNA chemistry, leading to large misrepresentations of RNA abundance. To alleviate the biases inherent in cloning RNA populations, we propose to carry out the directed evolution of T4 RNA ligase. We will use a novel emulsion method to evolve ligases that are sequence and structure non-specific. We will also expand conventional cloning methods to try to identify particular sub-populations of small RNAs, such as those that contain 5'-triphosphates. We will determine the relative efficacy of both our normalization attempts and our new cloning strategies through NextGen sequencing of both prepared mixes of RNAs and natural samples. Be undertaking this work we will likely overcome in a timely fashion what is only now coming to be realized as a gargantuan hurdle to the acquisition and interpretation of high-throughput sequence data for small RNAs. PUBLIC HEALTH RELEVANCE: New, high-throughput sequencing methods (NextGen sequencing) is providing a wealth of data on genomes and gene expression, much of which is highly relevant to understanding human health and to developing diagnostics and therapeutics for human disease. However, it appears as though these powerful methods do not accurately represent which small RNA molecules may be present in a cell. Such skewing could lead to errors in interpretation or to missing critical sequences relevant to health and disease (such as small, expressed sequences from viruses). In order to ensure accurate coverage of transcribed RNAs, we will design and evolve new reagents for preparing samples for NextGen sequencing.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10544-012-9721-0
发表时间: 2013-08
期刊: BIOMEDICAL MICRODEVICES
影响因子: 2.8
作者: [Wan, Yuan, Tamuly, Deepika, Allen, Peter B., Kim, Young-tae, Bachoo, Robert, Ellington, Andrew D., Iqbal, Samir M.]
通讯作者: Iqbal, Samir M.
DOI: 10.1002/0471142727.mb1512s105
发表时间: 2014-01-06
期刊: Current protocols in molecular biology
影响因子: --
作者: [Meyer, Adam J, Ellefson, Jared W, Ellington, Andrew D]
通讯作者: Ellington, Andrew D
DOI: 10.1039/c2lc40373k
发表时间: 2012-08-21
期刊: Lab on a chip
影响因子: 6.1
作者: [Allen PB, Arshad SA, Li B, Chen X, Ellington AD]
通讯作者: Ellington AD
Capture, isolation and release of cancer cells with aptamer-functionalized glass bead array.
用适体官能化的玻璃珠阵列捕获,分离和释放癌细胞。
DOI: 10.1039/c2lc21251j
发表时间: 2012-11-21
期刊: Lab on a chip
影响因子: 6.1
作者: [Wan Y, Liu Y, Allen PB, Asghar W, Mahmood MA, Tan J, Duhon H, Kim YT, Ellington AD, Iqbal SM]
通讯作者: Iqbal SM
Directed evolution of broadly fungible biosensors
  • 批准号:
    10587024
  • 项目类别:
  • 资助金额:
    $31.45万
  • 财政年份:
    2023
  • 负责人:
    Andrew D Ellington
  • 依托单位:
Directed evolution of polymerases that can read and write extremely long sequences
  • 批准号:
    10170542
  • 项目类别:
  • 资助金额:
    $18.3万
  • 财政年份:
    2020
  • 负责人:
    Andrew D Ellington
  • 依托单位:
Directed evolution of polymerases that can read and write extremely long sequences
  • 批准号:
    10548111
  • 项目类别:
  • 资助金额:
    $35.08万
  • 财政年份:
    2020
  • 负责人:
    Andrew D Ellington
  • 依托单位:
Directed evolution of polymerases that can read and write extremely long sequences
  • 批准号:
    9885765
  • 项目类别:
  • 资助金额:
    $32.97万
  • 财政年份:
    2020
  • 负责人:
    Andrew D Ellington
  • 依托单位:
海外基金